1. Home
  2. YMT vs LTRN Comparison

YMT vs LTRN Comparison

Compare YMT & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YMT

Yimutian Inc. American Depositary Shares

N/A

Current Price

$0.22

Market Cap

19.4M

Sector

Technology

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$2.78

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YMT
LTRN
Founded
2011
2013
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.4M
22.2M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
YMT
LTRN
Price
$0.22
$2.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.4M
1.3M
Earning Date
06-09-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.65
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.15
$1.11
52 Week High
$2.40
$5.74

Technical Indicators

Market Signals
Indicator
YMT
LTRN
Relative Strength Index (RSI) 32.00 65.87
Support Level $0.15 $2.49
Resistance Level $0.35 $3.79
Average True Range (ATR) 0.03 0.31
MACD 0.03 0.14
Stochastic Oscillator 31.78 96.00

Price Performance

Historical Comparison
YMT
LTRN

About YMT Yimutian Inc. American Depositary Shares

Yimutian Inc is the largest agricultural B2B platform in mainland China. It provide a comprehensive set of digital solutions to facilitate agricultural product transactions, ranging from searching, matching, to transaction facilitation and settlement. The company pride itself as the go-to platform for merchants by leveraging its inventive technology and industry know-how. Its platform had over 38 million merchants. It has also established approximately 12 offline stores in mainland China to trade agricultural products at cultivation and production sites with sellers and buyers.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

Share on Social Networks: